Sigyn Therapeutics, Inc. Balance Sheet
SIGY|5 years of annual SEC 10-K data (FY2014-FY2019)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Sigyn Therapeutics, Inc. had $0 in total assets with negative shareholders' equity of $910 as of FY2019.
Based on SEC 10-K filings.
| Item | FY2019 | FY2018 | FY2017 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Cash & Equivalents | $500 | $7.5K | $9.6K | $638.8K | $95 |
| Inventory | $588.1K | $723.6K | - | $509.8K | - |
| Current Assets | $588.6K | $733.2K | - | $1.2M | - |
| PP&E (Net) | $3.1K | $15.5K | - | $4.8K | - |
| Total Assets | $0 | $862.0K | - | $1.4M | - |
| Current Liabilities | $910 | $4.6M | - | $1.5M | - |
| Shareholders' Equity | -$910 | -$3.7M | -$2.1M | -$82.0K | - |